Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
Medicare bills are increasing for millions of Americans despite a $2,000 prescription drug cap beginning in 2025, as premiums ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Health insurance companies selling private Medicare Advantage plans in the US would see a greater increase in payments in ...
MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...